BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Huth C, Bauer A, Zierer A, Sudduth-Klinger J, Meisinger C, Roden M, Peters A, Koenig W, Herder C, Thorand B. Biomarker-defined pathways for incident type 2 diabetes and coronary heart disease-a comparison in the MONICA/KORA study. Cardiovasc Diabetol 2020;19:32. [PMID: 32164753 DOI: 10.1186/s12933-020-01003-w] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Wu L, Zhang Y, Zhao H, Rong G, Huang P, Wang F, Xu T. Dissecting the Association of Apolipoprotein E Gene Polymorphisms With Type 2 Diabetes Mellitus and Coronary Artery Disease. Front Endocrinol 2022;13:838547. [DOI: 10.3389/fendo.2022.838547] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Osawa Y, Tanaka T, Semba RD, Fantoni G, Moaddel R, Candia J, Simonsick EM, Bandinelli S, Ferrucci L. Proteins in the pathway from high red blood cell width distribution to all-cause mortality. EBioMedicine 2022;76:103816. [PMID: 35065420 DOI: 10.1016/j.ebiom.2022.103816] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Birukov A, Polemiti E, Jäger S, Stefan N, Schulze MB. Fetuin-A and risk of diabetes-related vascular complications: a prospective study. Cardiovasc Diabetol 2022;21:6. [PMID: 34998417 DOI: 10.1186/s12933-021-01439-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
4 Zheng J, Huang M, Huang Q, Chen Q, Chen Z. The relationship between fetuin-A and coronary atherosclerotic heart disease (CHD) and CHD-related risk factors: A retrospective study. Medicine (Baltimore) 2021;100:e27481. [PMID: 34713826 DOI: 10.1097/MD.0000000000027481] [Reference Citation Analysis]
5 Thorand B, Zierer A, Büyüközkan M, Krumsiek J, Bauer A, Schederecker F, Sudduth-Klinger J, Meisinger C, Grallert H, Rathmann W, Roden M, Peters A, Koenig W, Herder C, Huth C. A Panel of 6 Biomarkers Significantly Improves the Prediction of Type 2 Diabetes in the MONICA/KORA Study Population. J Clin Endocrinol Metab 2021;106:e1647-59. [PMID: 33382400 DOI: 10.1210/clinem/dgaa953] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
6 Bauer A, Zierer A, Gieger C, Büyüközkan M, Müller-Nurasyid M, Grallert H, Meisinger C, Strauch K, Prokisch H, Roden M, Peters A, Krumsiek J, Herder C, Koenig W, Thorand B, Huth C. Comparison of genetic risk prediction models to improve prediction of coronary heart disease in two large cohorts of the MONICA/KORA study. Genet Epidemiol 2021;45:633-50. [PMID: 34082474 DOI: 10.1002/gepi.22389] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Peter RS, Jaensch A, Mons U, Schöttker B, Schmucker R, Koenig W, Brenner H, Rothenbacher D. Prognostic value of long-term trajectories of depression for incident diabetes mellitus in patients with stable coronary heart disease. Cardiovasc Diabetol 2021;20:108. [PMID: 33985516 DOI: 10.1186/s12933-021-01298-3] [Reference Citation Analysis]
8 Prausmüller S, Resl M, Arfsten H, Spinka G, Wurm R, Neuhold S, Bartko PE, Goliasch G, Strunk G, Pavo N, Clodi M, Hülsmann M. Performance of the recommended ESC/EASD cardiovascular risk stratification model in comparison to SCORE and NT-proBNP as a single biomarker for risk prediction in type 2 diabetes mellitus. Cardiovasc Diabetol 2021;20:34. [PMID: 33530999 DOI: 10.1186/s12933-021-01221-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
9 Magalhães P, Zürbig P, Mischak H, Schleicher E. Urinary fetuin-A peptides as a new marker for impaired kidney function in patients with type 2 diabetes. Clin Kidney J 2021;14:269-76. [PMID: 33564428 DOI: 10.1093/ckj/sfaa176] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Zanini JC, Pietzner M, Langenberg C. Integrating Genetics and the Plasma Proteome to Predict the Risk of Type 2 Diabetes. Curr Diab Rep 2020;20:60. [PMID: 33033935 DOI: 10.1007/s11892-020-01340-w] [Reference Citation Analysis]
11 Huemer MT, Huth C, Schederecker F, Klug SJ, Meisinger C, Koenig W, Rathmann W, Peters A, Thorand B. Association of endothelial dysfunction with incident prediabetes, type 2 diabetes and related traits: the KORA F4/FF4 study. BMJ Open Diabetes Res Care 2020;8:e001321. [PMID: 32690629 DOI: 10.1136/bmjdrc-2020-001321] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
12 Zhang Y, Jin JL, Cao YX, Zhang HW, Guo YL, Wu NQ, Zhu CG, Gao Y, Hua Q, Li YF, Xu RX, Li JJ. Lipoprotein (a) predicts recurrent worse outcomes in type 2 diabetes mellitus patients with prior cardiovascular events: a prospective, observational cohort study. Cardiovasc Diabetol. 2020;19:111. [PMID: 32646432 DOI: 10.1186/s12933-020-01083-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]